SRX Global is trading at $1.66, up 5.06%, with no clear catalyst identified for the September 29 rise.
- No September 29 company announcement was identified; the latest reported release was September 24, covering portfolio liquidations and a new Onconetix investment.
- That update does not establish a cause for the rise. Supplied sector context is negative for technology, while the broader market is nearly flat; neither clearly explains the gain.